News
Media
Conferences
Publications
CME/CE
Resources
Subscribe
About
Partnerships

|Articles|June 16, 2011

3D Surface Reconstruction Omphalocele at 10.5 weeks GA (>9mm diameter)

Author(s)Juan Carlos Pons

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Related Content

Kevin Ault, MD, on the clinician's role in maternal COVID-19 vaccine counseling

Kevin Ault, MD, on the clinician's role in maternal COVID-19 vaccine counseling

ByKevin Ault, MD

September 9th 2026

Certolizumab pegol receives FDA BTD for adverse pregnancy outcomes in APS

Certolizumab pegol receives FDA BTD for adverse pregnancy outcomes in APS

ByJoshua Fitch, Senior Editor

September 9th 2026

Amber Watters, MD, on anesthesia in external cephalic version for breech presentation

Amber Watters, MD, on anesthesia in external cephalic version for breech presentation

ByAmber Watters, MD, MS

September 8th 2026

Positively Pregnant tool helps patients time home pregnancy testing

ByAlexandra C. Sundermann, MD, PhD

September 7th 2026

ACOG's 2026-27 respiratory vaccine guidance, estradiol patch supply update, and more

ACOG's 2026-27 respiratory vaccine guidance, estradiol patch supply update, and more

ByJoshua Fitch, Senior Editor

September 7th 2026

Latest CME

Join Us at The Pathology Meeting in Las Vegas

In-Person + Virtual Event

Join Us at The Pathology Meeting in Las Vegas

October 5, 2026

Join Us at The Pathology Meeting in Las Vegas

In-Person + Virtual Event

Join Us at The Pathology Meeting in Las Vegas

October 4-5, 2026

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Case-based Simulation

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Rachel N. Grisham, MD

Trending on Contemporary OB/GYN

Certolizumab pegol receives FDA BTD for adverse pregnancy outcomes in APS

PMOS Awareness Month: Watch our expert panel discussion on PMOS

Phase 3 LUNA study: atogepant reduces menstrual migraine days vs. placebo

Kevin Ault, MD, on the clinician's role in maternal COVID-19 vaccine counseling

Society of Family Planning issues first guidance on deep and nonpalpable contraceptive implant removal